NCT04269993 Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis Status TERMINATED Phase PHASE2
NCT04268771 A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products Status COMPLETED Phase PHASE3
NCT04254146 Effects of Acute Exercise on BDNF Levels in Rheumatoid Arthritis Patients Status UNKNOWN Phase NA
NCT04251741 Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04247815 Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA Status COMPLETED Phase PHASE2
NCT04246762 Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4 Status COMPLETED Phase PHASE1
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04230213 A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT04227535 Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04227366 Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT04226131 MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics Status COMPLETED Phase NA
NCT04222920 Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity Status COMPLETED Phase PHASE4
NCT04210817 A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis Status WITHDRAWN Phase N/A